• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2400206 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2024-09-12 view
JYSB2400207 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2024-09-12 view
JYSB2400191 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2024-08-26 view
JYSB2400190 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2024-08-26 view
JYSZ2400034 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products License Renew 2024-06-21 view
JYSZ2400033 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products License Renew 2024-06-21 view
JYSB2300156 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2023-09-12 view
JYSB2300155 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2023-09-12 view
JTS2200110 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Disposable Import Drug Application 2022-12-31 view
JYSB2200017 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2022-02-11 view
JYSB2200018 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2022-02-11 view
JYSB2000654 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2020-12-25 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2021-01-06 view
JYSB2000653 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2020-12-25 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2021-01-06 view
JYSB2000426 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2020-09-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2020-09-11 view
JYSB2000425 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2020-09-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2020-09-11 view
JYSB2000332 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2020-06-30 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2020-07-01 view
JYSB2000331 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2020-06-30 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2020-07-01 view
JXSS2000016 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Import Drug Application 2020-05-27 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-05-26 view
JXSS2000017 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Import Drug Application 2020-05-27 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-05-26 view
JYSB2000157 注射用恩美曲妥珠单抗 trastuzumab emtansine Lyophilized Biological Products Supplementary Application 2020-05-16 上海罗氏制药有限公司 Shanghai Roche Pharmaceutical Co Ltd In Review 2020-05-15 view